Introduction and purpose Lupus nephritis (LN) is a major cause of morbidity and mortality in patients with SLE, a complex autoimmune disease characterised by loss of tolerance to self-nuclear antigens ...

Renal failure in multiple myeloma typically occurs when the kidneys fail to filter waste products from the blood, leading to ...

French researchers identify distinct immune profiles in checkpoint inhibitor–induced nephritis, revealing a neutrophil-driven ...

1 2 Methods The MISSION study is a Phase 1b/2, open-label study to evaluate safety, tolerability, and exploratory efficacy of zetomipzomib in patients with active systemic lupus erythematosus (SLE) ± ...

cCentre for Epidemiology Versus Arthritis, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health ...

aDepartment of Nephrology, China-Japan Friendship Hospital, Beijing, China bDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, ...

The following is a summary of “Influence of interstitial lung disease on systemic sclerosis hospitalizations, a national study (2002–2020),” published in the May 2025 issue of Advances in Rheumatology ...

IgAV nephritis frequently results in chronic kidney disease and ... Renal pathology findings included diffuse mesangial proliferation, no crescent or interstitial lesions, and segmental sclerosis ...

Moreover; he had acute and progressive renal failure. His kidney biopsy showed acute interstitial nephritis. Serum complements, ANA, ANCA, protein electrophoresis, IgG4 level, and hepatitis B and C ...

Voclosporin treatment can further reduce the urinary protein to creatinine ratio (UPCR) to less than 0.5 g/g in a subset of patients with lupus nephritis, investigators reported at LUPUS 2025 ...

Patients with intermediate-onset lupus nephritis were associated with poorer renal outcomes compared against those with early-onset disease. Patients who develop lupus nephritis (LN) within 1 to 5 ...

Objective: This study aimed to compare the efficacy and safety (infection events) between rituximab (RTX), tacrolimus (TAC), mycophenolate mofetil (MMF), and cyclophosphamide (CYC) as induction ...